UPDATE: MHRA Class 4 Medicines Defect Information: Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets, Naprosyn EC 500mg Gastro-Resistant Tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an update, following the medicines defect notification shared on 23 February 2022, this has been updated to reflect an update
Source: Royal Pharmaceutical Society News - Category: Drugs & Pharmacology Source Type: news